MXC-Cannabis-Research-Permit-Granted-for-RMIT-Programs.PDF
"...The receipt of a Permit enables MXC to proceed with botanical research projects in collaboration
with RMIT University which includes cultivating and breeding strains in order to test against cancer
cells, with the aim of optimising efficacy. Strains will be screened for anticancer activity, initially
melanoma and prostate cancers.
The botanical research will leverage existing MGC Pharma IP and focus on identifying new
cannabinoids and formulas to find new treatments. Initially the research analysis is to specifically
target efficacy against melanoma, prostate and other cancer cells."
Looking forward to seeing the results of research!
- Forums
- ASX - By Stock
- RGT
- Ann: MXC Cannabis Research Permit Granted for RMIT Programs
Ann: MXC Cannabis Research Permit Granted for RMIT Programs, page-2
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
|
|||||
Last
29.0¢ |
Change
-0.025(7.94%) |
Mkt cap ! $13.13M |
Open | High | Low | Value | Volume |
29.0¢ | 29.0¢ | 29.0¢ | $688 | 2.372K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1033 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1033 | 0.290 |
1 | 2500 | 0.280 |
1 | 9600 | 0.275 |
1 | 10000 | 0.270 |
1 | 4000 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 50000 | 1 |
0.315 | 2825 | 2 |
0.335 | 8000 | 1 |
0.340 | 44885 | 3 |
0.370 | 1056 | 1 |
Last trade - 11.01am 03/07/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online